- Home
- VTYX vs THCH Comparison
VTYX vs THCH Comparison
Compare VTYX & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- THCH
- Stock Information
- Founded
- VTYX 2018
- THCH 2018
- Country
- VTYX United States
- THCH China
- Employees
- VTYX N/A
- THCH N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- THCH Blank Checks
- Sector
- VTYX Health Care
- THCH Finance
- Exchange
- VTYX Nasdaq
- THCH Nasdaq
- Market Cap
- VTYX 154.9M
- THCH 141.1M
- IPO Year
- VTYX 2021
- THCH N/A
- Fundamental
- Price
- VTYX $2.08
- THCH $2.99
- Analyst Decision
- VTYX Buy
- THCH
- Analyst Count
- VTYX 4
- THCH 0
- Target Price
- VTYX $11.33
- THCH N/A
- AVG Volume (30 Days)
- VTYX 1.9M
- THCH 11.7K
- Earning Date
- VTYX 02-25-2025
- THCH 11-12-2024
- Dividend Yield
- VTYX N/A
- THCH N/A
- EPS Growth
- VTYX N/A
- THCH N/A
- EPS
- VTYX N/A
- THCH N/A
- Revenue
- VTYX N/A
- THCH $207,029,179.00
- Revenue This Year
- VTYX N/A
- THCH N/A
- Revenue Next Year
- VTYX N/A
- THCH N/A
- P/E Ratio
- VTYX N/A
- THCH N/A
- Revenue Growth
- VTYX N/A
- THCH N/A
- 52 Week Low
- VTYX $1.67
- THCH $2.78
- 52 Week High
- VTYX $11.48
- THCH $9.05
- Technical
- Relative Strength Index (RSI)
- VTYX 45.64
- THCH 33.09
- Support Level
- VTYX $1.83
- THCH $2.91
- Resistance Level
- VTYX $2.61
- THCH $3.75
- Average True Range (ATR)
- VTYX 0.18
- THCH 0.23
- MACD
- VTYX -0.03
- THCH -0.04
- Stochastic Oscillator
- VTYX 32.26
- THCH 11.76
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.